Pregnancy And Fetal Outcomes After Paternal Exposure To Disease Modifying Drugs For Multiple Sclerosis (P4.157)

@inproceedings{Amato2014PregnancyAF,
  title={Pregnancy And Fetal Outcomes After Paternal Exposure To Disease Modifying Drugs For Multiple Sclerosis (P4.157)},
  author={Maria Pia Amato and Marta Giannini and Emilio Portaccio and Annalisa Ghezzi and Bahia Hakiki and Luisa Past{\`o} and Lorenzo Razzolini and Chiara Pecori and Andrea Sturchio and Laura De Giglio and Carlo Pozzilli and Damiano Paolicelli and Maria Trojano and Maria Giovanna Marrosu and Francesco Patti and Gianluigi Mancardi and Claudio Solaro and Rocco Totaro and Maria Rosaria Tola and Giovanna de Luca and Alessandra Lugaresi and Lucia Moiola and Vittorio Martinelli and Giancarlo Comi},
  year={2014}
}
OBJECTIVE: to assess pregnancy and fetal outcomes after father’s exposure to DMD (Disease Modifying Drugs), using the previously collected Italian Pregnancy Dataset (Amato et al., Neurology 2010). BACKGROUND: there is a dearth of information on the role of paternal exposure to DMD for multiple sclerosis (MS) on pregnancy and fetal outcomes. METHODS: we recruited MS male patients, prospectively followed-up in 21 Italian MS Centres, whose partners were pregnant in the period 2002-2008. Patients… CONTINUE READING

Topics from this paper.

Similar Papers

Loading similar papers…